Published in J Antimicrob Chemother on February 15, 2010
Nanomedicine in the Management of Microbial Infection - Overview and Perspectives. Nano Today (2014) 0.87
Materials innovation for co-delivery of diverse therapeutic cargos. RSC Adv (2013) 0.84
Baicalein attenuates the quorum sensing-controlled virulence factors of Pseudomonas aeruginosa and relieves the inflammatory response in P. aeruginosa-infected macrophages by downregulating the MAPK and NFκB signal-transduction pathways. Drug Des Devel Ther (2016) 0.84
Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.83
Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. Antimicrob Agents Chemother (2013) 0.77
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms. Pharmaceutics (2016) 0.75
Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches. Int J Mol Sci (2016) 0.75
In vitro and in vivo activities of ticarcillin-loaded nanoliposomes with different surface charges against Pseudomonas aeruginosa (ATCC 29248). Daru (2012) 0.75
Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol (2006) 1.63
Pseudomonas aeruginosa-induced lung injury: role of oxidative stress. Microb Pathog (2002) 1.09
Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J Antimicrob Chemother (2009) 1.06
Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol (2002) 1.05
Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer. Breast Cancer Res Treat (2007) 1.00
Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting. Micron (2007) 0.97
Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2006) 0.97
Shifting wavelengths of ultraweak photon emissions from dying melanoma cells: their chemical enhancement and blocking are predicted by Cosic's theory of resonant recognition model for macromolecules. Naturwissenschaften (2014) 0.95
Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother (2004) 0.94
Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents. Int J Pharm (2008) 0.93
Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer. J Cancer Res Clin Oncol (2010) 0.92
Photon emissions from human brain and cell culture exposed to distally rotating magnetic fields shared by separate light-stimulated brains and cells. Brain Res (2011) 0.92
The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Drug Deliv (2004) 0.90
HSG cells differentiated by culture on extracellular matrix involves induction of S-adenosylmethione decarboxylase and ornithine decarboxylase. J Cell Physiol (2005) 0.89
EGFR and ErbB2 differentially regulate Raf-1 translocation and activation. Lab Invest (2002) 0.88
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Int J Pharm (2007) 0.87
Antimicrobial efficacy of a new antibiotic-loaded poly(hydroxybutyric-co-hydroxyvaleric acid) controlled release system. J Antimicrob Chemother (2004) 0.87
Photon emission from melanoma cells during brief stimulation by patterned magnetic fields: is the source coupled to rotational diffusion within the membrane? Gen Physiol Biophys (2013) 0.87
Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells. Can J Physiol Pharmacol (2010) 0.86
Protective Effects of Liposomal N-Acetylcysteine against Paraquat-Induced Cytotoxicity and Gene Expression. J Toxicol (2011) 0.85
Preparation and characterization of dehydration-rehydration vesicles loaded with aminoglycoside and macrolide antibiotics. Int J Pharm (2005) 0.85
Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study. Int J Antimicrob Agents (2006) 0.85
Cytotoxicity and gene array analysis of alveolar epithelial A549 cells exposed to paraquat. Chem Biol Interact (2010) 0.85
Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia. J Antimicrob Chemother (2007) 0.84
Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer. Cancer Epidemiol (2010) 0.84
Liposomes as a carrier for gentamicin delivery: development and evaluation of the physicochemical properties. Int J Pharm (2008) 0.84
Cell adhesion and cancer: is there a potential for therapeutic intervention? Expert Opin Ther Targets (2007) 0.84
Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity. J Drug Target (2013) 0.83
Growth of injected melanoma cells is suppressed by whole body exposure to specific spatial-temporal configurations of weak intensity magnetic fields. Int J Radiat Biol (2010) 0.82
Adhesion dependent signalling in the tumour microenvironment: the future of drug targetting. Curr Pharm Des (2006) 0.81
Treatment of THP-1 cells with Uncaria tomentosa extracts differentially regulates the expression if IL-1beta and TNF-alpha. J Ethnopharmacol (2006) 0.81
Temporally-patterned magnetic fields induce complete fragmentation in planaria. PLoS One (2013) 0.81
Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa. Int J Pharm (2009) 0.80
Uncaria tomentosa acts as a potent TNF-alpha inhibitor through NF-kappaB. J Ethnopharmacol (2009) 0.80
Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis. PLoS One (2009) 0.79
Safety of archaeosome adjuvants evaluated in a mouse model. J Liposome Res (2002) 0.79
Importance of divalent cations in nanolipoplex gene delivery. J Pharm Sci (2007) 0.79
Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model. J Antimicrob Chemother (2012) 0.79
Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinase. Carcinogenesis (2002) 0.79
Intermittent exposures to nanoTesla range, 7 Hz, amplitude-modulated magnetic fields increase regeneration rates in planarian. Int J Radiat Biol (2013) 0.78
Liposomal antibiotics for the treatment of infectious diseases. Expert Opin Drug Deliv (2013) 0.78
Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa. J Pharm Pharmacol (2011) 0.78
Formulation and evaluation of floating tablet of H2-receptor antagonist. Drug Dev Ind Pharm (2015) 0.78
Hydrogen peroxide stress provokes a metabolic reprogramming in Pseudomonas fluorescens: enhanced production of pyruvate. J Biotechnol (2013) 0.78
Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection. Antimicrob Agents Chemother (2012) 0.78
Characterization of human septic sera induced gene expression modulation in human myocytes. Int J Clin Exp Med (2009) 0.78
Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer. Breast Cancer Res Treat (2009) 0.77
N-acetylcysteine modulates the cytotoxic effects of Paclitaxel. Chemotherapy (2011) 0.77
Safety and pharmacokinetic studies of liposomal antioxidant formulations containing N-acetylcysteine, α-tocopherol or γ-tocopherol in beagle dogs. Toxicol Mech Methods (2013) 0.77
Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. Antimicrob Agents Chemother (2013) 0.77
Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin. Int J Pharm (2008) 0.77
Nasal and pulmonary vaccine delivery using particulate carriers. Expert Opin Drug Deliv (2015) 0.77
Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries. J Endotoxin Res (2007) 0.77
Digitized quantitative electroencephalographic patterns applied as magnetic fields inhibit melanoma cell proliferation in culture. Neurosci Lett (2012) 0.77
Toxicity of ricin toxin A chain in rats. Drug Chem Toxicol (2012) 0.77
Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase. Microbiology (2014) 0.76
Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa. Can J Physiol Pharmacol (2011) 0.76
The effect of aminoglycoside antibiotics on the thermodynamic properties of liposomal vesicles. J Liposome Res (2010) 0.76
Characterization of the interaction between liposomal formulations and Pseudomonas aeruginosa. J Liposome Res (2010) 0.76
Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa. Ther Deliv (2014) 0.75
Non-targeted effects and radiation-induced carcinogenesis: a review. J Radiol Prot (2016) 0.75
Acute toxicity study of liposomal antioxidant formulations containing N-acetylcysteine, α-tocopherol, and γ-tocopherol in rats. J Liposome Res (2012) 0.75
Fumarate metabolism and ATP production in Pseudomonas fluorescens exposed to nitrosative stress. Antonie Van Leeuwenhoek (2014) 0.75
Co-administration of aqueous ginseng extract with tobramycin stimulates the pro-inflammatory response and promotes the killing of Pseudomonas aeruginosa in the lungs of infected rats. Can J Physiol Pharmacol (2013) 0.75
Correction: Identification and treatment of the Staphylococcus aureus reservoir in vivo. J Exp Med (2016) 0.75
Treatment of ricin A-chain-induced hepatotoxicity with liposome-encapsulated N-acetylcysteine. J Drug Target (2011) 0.75
Disposition of 3H-cholesteryl ether labeled liposomes following intravenous administration to mice: comparison with an encapsulated 14C-inulin as aqueous phase marker. Drug Deliv (2003) 0.75